logo-loader
AIM:MXCT

MaxCyte Inc

Market:
AIM
Market Cap:
£96.15 m
Price
167.50 GBX
Change
-2.33%
52 weeks high
185.00
52 weeks low
95.00

In brief

We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines.

Deep dive We explore the investor case for growth companies

Snapshot

  • Pioneering work in gene editing to tackle cancer
  • "Highly optimistic" during coronavirus crisis
  • Deal with Allogene Therapeutics